FAQ • Education • Posters • Resources • Engage • Supporters • #CPNPcares

CPNP 2020 Scientific Poster Session Abstracts

Below is a complete list of the posters that will be presented at CPNP 2020. There will be two different poster sessions, and award finalists will present their posters on the same day as their platform presentation.

Click on the column headings to sort the table below.

Use the search box to quickly locate an abstract by any data in the column, including "PGY2"! The site search provides full-text search of all 2,650+ abstracts that have been presented at the CPNP Annual Meeting over the years. For a brief video introduction to the poster session technology, see the FAQ.

Title
A Pharmacist Driven Intervention for Optimizing Dyslipidemia Management in Patients on Antipsychotic Therapy
A Potential Case of Refeeding Syndrome in a Patient with Severe Mental Illness
A Retrospective Chart Review of Key Factors of Medication Assisted Treatment (MAT) Outpatient Program Success: A Focus on the Pharmacy-Related Characteristics
A Systematic Review of the Understandability, Actionability, and Quality of Online Resources for the Self-Management of Bipolar Disorder
Acute Dystonia or Angioedema: Haloperidol-Induced Adverse Drug Reaction in a Pediatric Patient
Addition and Impact of a Clinical Pharmacist to a Community Hospital Psychiatric Consult Liaison Team
Alcohol-Based Hand Sanitizer Abuse: A Case Report
Alice in Wonderland Syndrome in a patient with schizoaffective disorder at a state hospital
An Analysis of Student Pharmacists’ Perceived Stress on Empathy Levels
An Investigation of the Utilization of Benzodiazepines in Veterans at a Federal Health Care Center
Anticholinergic Burden in Patients Admitted to a State Psychiatric Hospital and Development of a Pharmacist-Led Anticholinergic Burden Support Service
Antidepressant Medication Adherence in the Outpatient Setting of the Veteran Population
Antipsychotic Alternative after Incidence of Hematologic Changes with Divalproex and Quetiapine: A Case Report in a Pediatric Patient
Antipsychotic Continuation at Discharge for Medical Inpatients Treated for Delirium
Antipsychotic Factors Related to Time to Competency for Forensic Inpatients in a State Psychiatric Facility
Antipsychotic Polypharmacy & Chlorpromazine Dose Equivalents in Psychiatric Inpatients
Assessing Adherence in Patients Using Long-Acting Injectable Antipsychotics
Assessing Perception and Knowledge of USC School of Pharmacy Students Regarding Mental Health and LGBTQ+ Care
Assessing Psychiatric Hospitalizations and Adherence to Outpatient Mental Health Appointments Following Initiation of Buprenorphine Extended-Release Injection
Assessing the Clinical Utility of Pharmacogenetic Testing in Hospitalized Adult Patients in an Acute Inpatient Psychiatric Facility
Assessing the Presence of Mental Health Stigma in an Academic Medical Center
Assessing the Safety of Atypical Antipsychotic Medications in Pediatric Patients Diagnosed with ADHD
Assessment of Adverse Effects of Zolpidem, Zaleplon, and Eszopiclone in a Veteran Population
Assessment of Benzodiazepine Utilization Pre- and Post-implementation of an Alcohol Withdrawal Protocol
Assessment of Long-acting Injectable Antipsychotics in a Free Replacement Program and the Possible Prevention of Hospital Readmissions
Assessment of mental health needs and barriers to care in students enrolled in Doctor of Pharmacy programs
Assessment of Mental Health Stigma in Pharmacy Students After Implementation of a Mental Health Focused Health Fair
Assessment of Psychiatric Inpatients Admitted on an ACEI or an ARB and the Incidence of suicidal Ideations or Suicide Attempts
Assessment of Student Pharmacist Sleep Habits
Atomoxetine for the Treatment of Neurogenic Orthostatic Hypotension
Benzodiazepine Deprescribing Following Academic Detailing of Prescribers and Disbursement of Direct-to-Consumer Materials to Veterans Affected by Benzodiazepine-Opioid Co-Prescribing
BoilerWoRx Outreach: Analyzing Changes in Attitudes Toward Substance Use Disorders, MAT Therapy, Harm Reduction, and Naloxone
Buprenorphine for Asphyxial Non-Suicidal Self-Injury in an Opioid Naïve Patient: A Case Report.
Characterization of Inpatient Pain Management for Patients Admitted to a Psychiatric Hospital with a Home Opioid Prescription
Clinical and Economic Value of Esketamine Nasal Spray: A Literature Review
Clinical Implementation of Pharmacogenomic Testing at a Forensic Psychiatric Hospital: A Pilot Study Examining Implementation Strategies, Prescriber Acceptability, and Barriers to the Service
Clinicians’ Perspectives on Extended-Release Naltrexone to Treat Opioid Use Disorder in Outpatient Settings: Results from an Online Survey
Combinatorial Pharmacogenomic Testing Improves Outcomes for Patients Taking Medications with Gene-Drug Interactions in a Randomized, Controlled Trial
Community Pharmacist Impact and Perceptions of Patient Benefit Following Implementation of an Evidence-Based Opioid Use Disorder Training Program
Community Pharmacists’ Perceptions of Quality among Buprenorphine Prescribers
Comparing Student Pharmacist and Pharmacist Perceived Role in Depression Screening and Suicide Prevention
Comparison of Health-Care Utilization for Patients Receiving Long-Acting Injectable Antipsychotics in a Psychiatric Hospital Versus Following Discharge
Comparison of Lithium and Second Generation Antipsychotics for Treating Bipolar Disorder in Older Veterans
Comparison of Lithium Related Toxicity Following Changes in Lab Monitoring Requirements
Comparison of Metabolic Adverse Effects with Clozapine Compared to Olanzapine
Complexities of Medication Therapy in Managing Bipolar Disorder in a Patient with a Nothing Per Mouth (NPO) order: A Case Report
Compliance With Suicide Risk Identification Protocol Between Mental Health Pharmacists and Other Healthcare Providers at a Veterans Affairs Health Care System
CPNP Collegiate Chapter: Student Pharmacists Bridging the Gap with Community Partnerships
Deploying Student Pharmacists for Harm Reduction for Opioids through Community Pharmacist Engagement
Depression Care and Suicide Risk Assessment at a Community Health Center in Los Angeles
Description of a Novel Advanced Pharmacy Practice Experience in Addiction Medicine
Description of Psychiatric Pharmacist-led Psychotropic Medication Deprescribing in Older Adults
Description of the Pharmacist’s Role within a Homeless Outreach Program
Development and Implementation of a Borderline Personality Disorder Treatment Protocol at a Veterans Affairs Medical Center
Development and Implementation of a Collaborative Physician-Pharmacist Care Model for Medication Assisted Treatment with Buprenorphine/Naloxone
DNA, Easy as 1-2-3: Design and Implementation of a Pharmacogenomics Consult Service in High-Risk Patients
Do Second Generation Long-Acting Injectable Antipsychotics Improve Adherence?
Domoic Acid and Related Marine Harmful Algae Bloom (HAB) Neurotoxins: Risks, Pathogenesis, Prevention, and Treatment Implications
Drug Use Evaluation (DUE) of Lithium Use at a State Psychiatry Facility Supports Need for Improved Monitoring
Drug-drug Interaction Studies (DDIs) with Coadministration of Cannabidiol (CBD) and Clobazam (CLB), Valproate (VPA), Stiripentol (STP) or Midazolam (MDZ) in Healthy Volunteers (HVTs) and Adults with Epilepsy
Early Improvement of PANSS Items in Patients with Schizophrenia Treated with Brexpiprazole: a Post Hoc Analysis of Three Randomized Studies
Educating Student-Athletes on Medications Used for the Treatment of Depression and Anxiety as a Component of an APPE Integrating Pharmacy Practice and Pharmaceutical Science Faculty
Effect of Cannabidiol Products on Mental Health Disorders
Effect on Hospital Readmission Rates in Veterans Treated with Typical vs. Atypical Long-Acting Injectable Antipsychotics
Effectiveness of Naltrexone Oral Versus Long-acting Injection For Alcohol Use Disorder Among Veteran Patients
Effectiveness of Paliperidone Palmitate One-Month Long-Acting Injection in Obese Versus Non-Obese Patients
Effects of Antidepressants and Depression on Driving Outcomes in the Elderly
Effects of Barcode Medication Administration (BCMA) Implementation on Medication Error Reporting for Long-Acting Injectables
Efficacy and Safety of Lumateperone (ITI-007) 42 mg in the Treatment of Schizophrenia: A Pooled Analysis of Randomized Clinical Trials
Emergency Treatment Option Prescribing Trends for Inpatient Pediatric Psychiatry
Enhancing Education of Family Medicine Residents: Survey Results of Interprofessional Psychiatry and Medical Care Conferences Across Two Outpatient Health Systems
Esketamine, in Conjunction With Antidepressant Monotherapy or Augmentation Therapy, Reduces Depressive Symptoms in Patients With Major Depressive Disorder and Active Suicidal Ideation With Intent
Estimating Pharmacy Adherence in a Mental Health Population
Evaluating Differences in Learning Outcomes between Pharmacy Students Enrolled in a Conventional versus Vertically-Integrated Neuropsychiatric Curriculum
Evaluating HIV Pre-Exposure Prophylaxis Prescribing within a Veterans Affairs Health Care System
Evaluating Outcomes of a Pharmacist Medication Management Program for Outpatient Treatment of Opioid Dependence
Evaluating Outcomes of Veterans on Long-acting Injectable Antipsychotics
Evaluating the Decision to “Double Down”: Implementation of a Pharmacy Consult to Optimize Risk Mitigation for Concomitant Opioid and Benzodiazepine Therapy
Evaluating the Efficacy of Melatonin vs. Diphenhydramine in Sleep and Next-Day Performance in Pediatric Patients on an Inpatient Psychiatric Unit
Evaluating the Impact of a Pharmacist-Managed Outreach Clinic at a Day Shelter for Homeless Veterans
Evaluating the Impact of Long-Acting Injectable Antipsychotics Versus Oral Antipsychotics on Psychiatric Hospitalization Rates in Veterans with Chronic Schizophrenia
Evaluating the Impact of Oral to Long Acting Injectable Antipsychotic Conversion in a Veteran Population with Schizophrenia
Evaluation of a Standardized Order Set for Treatment of Acute Agitation in the Emergency Department and Impact on Evidence-based Rating Scale Score Reduction
Evaluation of Benzodiazepine Use in Post-Traumatic Stress Disorder (PTSD) utilizing the Psychotropic Drug Safety Initiative (PDSI) tool
Evaluation of Initial Atypical Antipsychotic Monitoring Parameters in Children and Adolescents
Evaluation of Inpatient Lithium Monitoring Practices in a Public Health and Hospital System
Evaluation of Low Dose Prazosin for PTSD Associated Nightmares in Children and Adolescents
Evaluation of Metabolic Side Effects in Patients with Posttraumatic Stress Disorder Using Atypical Antipsychotics
Evaluation of Prescribing Patterns Of Antipsychotic Treatment In Adults With Schizophrenia Receiving Antipsychotic Polypharmacy Versus Antipsychotic Monotherapy
Evaluation of Safety and Efficacy of Newly-Approved Pimavanserin for Parkinson’s Disease Associated Psychosis
Evaluation of Test Anxiety and Its Effect on Pharmacy Students
Evaluation of the Clinical Impact of Different Administration Sites for Paliperidone Palmitate in Psychiatric Patients at a Veteran’s Affairs Medical Center
Evaluation of the Implementation of a Protocol Examining First Episode Psychosis in an Acute, Inpatient Psychiatry Setting
Evaluation of the Prescribing Practices of Prazosin at a Federally Qualified Health Center
Examining the Association between Statin Use and New-Onset Dementia Risk
Expanding Naloxone Education in the PharmD Curriculum
Expanding the Role of Pharmacists in Mental Health and Addiction Treatment Through a Post Graduate Year One Behavioral Health Pharmacy Residency Program
Exploring Perceptions of Adverse Drug Reactions Among Pharmacists and Providers in an Inpatient Psychiatric Facility
Folic Acid Metabolism and Depression: A Review of the Role of Pharmacogenomic Testing in Folic Acid and L-Methylfolate Supplementation for Patients with Major Depressive Disorder
Gabapentin: Utilization Evaluation at Mental Health Facilities
Hematologic Adverse Reactions with Multiple Antipsychotics: A Case Report
Hope Stems: Implementation of a Public Health Campaign at a College Campus
Identifying Opportunities for Pharmacist Optimization of Antipsychotic Therapy in Early Psychosis
Impact of a Pharmacy Consult Service on Reduction of Benzodiazepine Use in High-Risk Patient Populations: One Year Follow-up
Impact of a Required Neuropsychiatric Course on Mental Health Stigma among Students Enrolled in an Accelerated Pharmacy Program
Impact of Academic Detailing on Clinical Pharmacy Specialist Involvement in Medication Assisted Treatment for Opioid Use Disorder in a Primary Care Setting
Impact of academic detailing on opioid-benzodiazepine co-prescribing at Veterans Health Administration.
Impact of Alpha-Stim device for the treatment of anxiety, depression, sleep and pain in Veterans at the Central Texas Veterans Healthcare System
Impact of an Interactive Registry Tracking Geriatric Patients Prescribed Anticholinergic Antidepressants
Impact of Continuing Education Focused on Drugs of Abuse for High School Faculty and Staff
Impact of Integrated Behavioral Health Services on Adherence to Long-Acting Injectable Antipsychotics
Impact of Medication for Disruptive Mood Dysregulation Disorder
Impact of Medications on Electroconvulsive Therapy Outcomes
Impact of Pharmacist Counseling on Psychiatric Readmission Rates
Impact of Pharmacist Interventions on Dosing and Administration of Long-Acting Injectable Antipsychotics
Impact of Pharmacist Involvement in Psychiatric Rounds on Psychotropic Medication Prescribing in an Institutionalized Forensic Population
Impact of Pharmacy Concierge Services on Psychiatric Readmissions at a Large Academic Medical Center
Impact of Quick-Order Set Implementation for Paliperidone Palmitate Long-Acting Injectables in a Veterans Affairs Health Care System
Implementation and Evaluation of a Pharmacist-Driven Discharge Medication Reconciliation Process on an Inpatient Psychiatric Unit
Implementation and Evaluation of Expanded Clinical Pharmacist Service within Residential Rehabilitation Treatment Programs at a Veterans Affairs Medical Center
Implementation and Impact of a Pharmacist-led Telemental Health Transitions of Care Clinic on Psychotropic Medication Adherence and Psychiatric Rehospitilzation
Implementation of a benzodiazepine de-prescribing tool for elderly Veterans at a Veterans Affairs Health Care System
Implementation of a Benzodiazepine Risk Review and Pharmacy Intervention
Implementation of a New Service for Esketamine Prescribing
Implementation of a Pharmacist-led Benzodiazepine Taper Clinic
Implementation of a Primary Care Mental Health Integration (PCMHI) Longitudinal Rotation and Telephone Clinic to Provide Pharmacy Mental Health Services to Patient Aligned Care Teams (PACT)
Implementation of a Scheduled Glucose Monitoring Protocol: A Study Investigating Asymptomatic Hypoglycemia During Weight Restoration on an Eating Disorders Unit
Implementation of an esketamine clinic at a Veterans Affairs Medical Center
Implementation of Depression Assessment in Ambulatory Care Clinics in Antigua, Guatemala
Implementation of Depression Screenings at a University-Affiliated Community Pharmacy: Obstacles and Solutions
Implementation of Psychiatric Clinical Pharmacy Services in an On-Campus University Counseling and Psychiatry Clinic
Implementation of Telehealth Clinical Pharmacy Services in a Mental Health Intensive Case Management (MHICM) Program at a Veterans Affairs Health Care System (VAHCS)
Implementing an Algorithm-based Protocol for the Pharmacologic Management of Acute Agitation and Aggression in Pediatrics: An Academic Medical Center Experience
Implementing Care Management Telephone Calls in a VA Integrated Care Community Based Outpatient Clinic
Implementing the Standardized CYP2D6 Genotype to Phenotype Translation System: A Meta-Analysis of CYP2D6 Polymorphisms and Risperidone Pharmacokinetics
Improving Access to Office-based Buprenorphine/Naloxone Therapy in Veterans
Incorporation of a Bar Code Medication Administration (BCMA) Protocol for Long-Acting Injectable Antipsychotics in a Primary Psychiatric Outpatient Care Setting
Increasing Access to Substance Use Disorder Pharmacotherapy at Veterans Affairs Hilo Community Based Outpatient Clinic
Increasing Naloxone Accessibility in the Homeless Population: A Pharmacist-Driven Initiative
Increasing Screening and Brief Interventions for Alcohol Use Disorder in a Department of Veteran Affairs Primary Care Clinic
Integration of Clinical Pharmacists into a Psychiatric Community Clinic Serving Patients with Moderate-to-Severe Mental Illness
Interprofessional Collaboration between Student Pharmacists and Student Psychologists
Interprofessional Controlled Substance-Related Communication Behaviors among Physicians and Community Pharmacists
Lessons Learned From An Unsuccessful Transition From Methadone To Buprenorphine Using A Published Micro-dose Protocol: A Case Report
Lifetime Cocaine Use and Depression: An Analysis of the National Health and Nutrition Examination Survey 2005-2018
Lofexidine for Acute Opioid Withdrawal: A Clinical Case Series
Long-acting Injectable Antipsychotics to Decrease Readmission Rates in Adolescents
Management of Psychiatric Disorders in Patients with Kleefstra Syndrome: A Case Report
Measuring the Effectiveness of Converting from paliperidone palmitate one-month injection to paliperidone palmitate three-month injection in an Outpatient Setting.
Mechanism of Action of DELEXIS®, a Novel, Oral, Colonic-Targeted Drug Delivery Platform
Medicaid Prescriber Dashboard Reports to Reduce Inappropriate Benzodiazepine Prescribing
Medication Assisted Treatment (MAT): The Pharmacy Student Perspective
Memantine for Benzodiazepine-Refractory Catatonia: A Case Report
Mental Health Resources in Pharmacy Schools
Methods to Mitigate Serotonergic Medication Withdrawal Symptoms: A Systematic Review
Midazolam Pharmacokinetics in adult patients on Veno-venous Extracorporeal Membrane Oxygenation.
Modified Overt Aggression Scale (mOAS) Development and Use in Monitoring Aggression on an Inpatient Psychiatric Unit
Naloxone Stand-Down Day: a Risk-Prioritized Telephone Outreach Event
Navigating Complexities of Brexanolone Administration: a Medication Use Evaluation
Olanzapine-Induced Fatty Liver: A Case Report
Olanzapine/Samidorphan for Schizophrenia: Weight Gain and Metabolic Outcomes in Phase 3 ENLIGHTEN-2 and Subsequent Long-Term, Open-Label Safety Study
Opioid Prescribing Among Non-Surgical Adult Inpatients on Discharge to Skilled Nursing Facilities
Opioid Prescribing Patterns for Cancer Patients with Opioid-dependency at an Academic Medical Center
Optimizing a pharmacy resident-led specialty mental health electronic consultation (e-consult) service at a Veterans Affairs Health Care System
Oral Haloperidol in Cannabinoid Hyperemesis Syndrome: Two Case Reports
Outcomes associated with once-daily versus multiple-daily dosing of buprenorphine/naloxone for Opioid Use Disorder
Outcomes Comparison Between Risperidone and Paliperidone Long-Acting Injectable Antipsychotics in Veterans
Outcomes of a Student-Led Smoking Cessation Program at a Women’s Shelter for Victims of Domestic Violence
Palatability Assessment of a New Amphetamine Extended-Release Tablet Formulation
Patient Attitudes about Tobacco Cessation in a Veteran Substance Use Disorder Population
Patient Experiences With Pharmacogenomic Testing: Systematic Review and Focus Groups to Inform Future Development of a Pharmacogenomic Literacy Assessment tool
Patient Perception of a Pharmacist’s Role on Their Mental Health Treatment Team
Perception of Awareness of Veteran’s Affairs Wellness Resources by Pharmacy Residency Directors and their Respective Residents
Persistence on Droxidopa for the Management of Orthostatic Hypotension at an Integrated Care Center
Pharmacist Managed Lithium in an Inpatient Academic Medical Center: Six Month Review
Pharmacist Role in an Outpatient Suboxone® Clinic: Improving Adherence Rates and Access for Veterans at Carl Vinson VA Medical Center (CVVAMC)
Pharmacist Wellness and Mental Health Analysis
Pharmacist-Driven Screening to Increase Utilization of Extended-Release Naltrexone for Alcohol Use Disorder in an Inpatient Psychiatric Hospital
Pharmacist-run Long-acting Injectable Antipsychotic and Addiction Therapy clinic: A 10-year Review
Pharmacokinetics of Synthetic Cathinones Found in "Bath Salts" in Mouse Brain and Plasma Using Liquid Chromatography - Mass Spectrometry
Pharmacy Students Knowledge and Attitudes Regarding Cannabidiol Uses, Risks, and Adverse Events
Pharmacy Wellness Committee: Improving the Lives of Our Colleagues
Potentially Inappropriate Bupropion Prescribing: Evaluation of an Inpatient Mental Health Unit
Promoting Innovative Mental Illness Education and Awareness in a Private University Setting
Providing Clinical Pharmacy Services within a Veteran’s Affairs Mental Health Intensive Case Management Program
Psychiatric manifestations in a patient with Neuro-Behcet’s Disease at a state hospital
Psychiatric Pharmacist Medication Management via Telehealth
Relationship Of Adverse Childhood Experiences (ACE) with Retention of Patients Receiving Medication Assisted Treatment (MAT) for Opioid Use Disorder
Risk Factors for ICU Transfer in Patients with Alcohol Withdrawal Syndrome
Serotonin-Norepinephrine Reuptake Inhibitor (SNRI) Cross-Reactivity Reaction
Shared Medical Appointment Clinic in a Substance Use Disorder Intensive Outpatient Program
Single-Dose Pharmacokinetics of Amphetamine Extended-Release Tablet (AMPH ER TAB) Compared with Amphetamine Extended-Release Oral Suspension (AMPH EROS)
Somnolence and Sedation with Lumateperone (ITI-007) Treatment: A Comparison of Morning and Evening Administration
Stamping Out Stigma With Naloxone Training and Simulation
Starting Patients on the Long-acting Antipsychotic Aripiprazole Lauroxil: Comparing 1-day and 21-day Initiation Regimens
Subcutaneous Buprenorphine in a Veteran Affairs Substance Use Disorder Clinic
Successful Continuation of Clozapine in Conjunction with Autologous Chimeric Antigen Receptor T-cell (CAR T) Immunotherapy
Suicide Prevention in Pharmacy: Raising Awareness and Reducing Stigma
Summary of Results of the Professional Affairs Committee Survey of Psychiatric Pharmacy Practice
Suspected Serotonin Syndrome in the Setting of Direct Antidepressant Switch
Systematic Review of Atypical Antipsychotics and Antidepressants in the Management of Agitation in Patients with Dementia
Taking a Chill Pill: A Case Report of Acute Hypothermia during Initial Inpatient Titration of Clozapine
Tardive Dyskinesia Negatively Impacts Patients’ Lives
The Association Between COMT Genotype And Bupropion Treatment Response In Outpatients With Major Depressive Disorder
The Broad Efficacy of Cariprazine Across Symptoms in Patients With Bipolar I Disorder: Post Hoc Analysis of Randomized, Placebo-Controlled Trials
The Clinical Utility of Combinatorial Pharmacogenomic Testing for Patients with Depression: A Meta-Analysis
The Effects of Opioid Use on Cognitive Processing Therapy for the Treatment of Post-Traumatic Stress Disorder Among Veterans
The Impact of a Pharmacist-Run Substance Use Disorder Transitions of Care Clinic on Medication-Assisted Treatment Retention Rates Post-Discharge
The Impact of Long-Acting Injectable (LAI) Antipsychotics on Aggression in a Long-Term State Forensic Psychiatric Facility
The More the Merrier: Using Primary Care Clinical Pharmacy Specialists for Alcohol Use Disorder Pharmacotherapy Management
The Use of Clozapine for Aggressive Behaviors in Involuntarily Committed Psychiatric Patients
Timing of Gabapentinoid Initiation During the Stabilization Phase of Methadone Treatment and Impact on Adherence and Safety in an Opioid Substitution Program
Transaminitis and Naltrexone-Induced Precipitated Withdrawal Following Kratom Use
Transcranial Magnetic Stimulation-Induced Mania with Psychosis: A Case Report
Transforming Pharmacy Intern Attitudes, Stigma, and Clinical Skills on an Adolescent Inpatient Psychiatry Unit
Treatment Responses with Long-Term Valbenazine in Patients with Tardive Dyskinesia
Trends of Anxiety in Professional Pharmacy Students
Un-MAT Needs: Effectiveness of Interprofessional Education on Initiation of Medication Assisted Treatment for Veterans Admitted with Alcohol Use Disorder
Utilizing Patient Empowerment to Decrease Benzodiazepine Use Among Older Adults within a Veterans Affairs Healthcare System
Utilizing The Clinical Global Impressions (CGI) Clinician Rating Scale to Measure Patient Care Outcomes: Expanded Retrospective Review Of Comprehensive Medication Management (CMM) Services Over Four Years.
Utilizing the Layered Learning Practice Model to Expand and Sustain Patient Medication Education Groups at an Inpatient Psychiatric Hospital
Utilizing Workflow Intervention Techniques to Increase Antidepressant Adherence and Engagement in Patients Within a Primacy Care Mental Health Setting
Validation of an Algorithm for the Assessment, Management and Monitoring of Drug-induced QTc Prolongation in the Psychiatric Population.
Vasopressor-Refractory Shock from Clozapine Overdose Treated with Synthetic Angiotensin II Infusion
Veteran Adherence to Oral Versus Injectable Alcohol Use Disorder Medication Treatment
Women's Health Management in Patients with Serious Mental Illness